During the past decade, H. Río Carrión conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "H. Río Carrión" #1 sponsor was "ALK-Abelló A/S" with 1 trials, followed by "Adacyte Therapeutics SL" with 1 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored, "Hospital Universitario Getafe" with 1 trials sponsored and "Laboratorios Leti, S.L." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "H. Río Carrión" #1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator, "Hoffmann-La Roche" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "H. Río Carrión" are "Acute Lymphoblastic Leukemia" (1 trials), "Acute Respiratory Failure" (1 trials), "Allergic Rhinoconjunctivitis" (1 trials), "Atrial Fibrillation" (1 trials) and "Breast Cancer" (1 trials). Many other conditions were trialed in "H. Río Carrión" in a lesser frequency.

Most popular intervention types in "H. Río Carrión" are "Drug" (4 trials), "Biological" (1 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "AVANZ Phleum pratense" (1 trials), "Adacolumn" (1 trials), "Allergen extract (Phleum pratense)" (1 trials), "Cyclophosphamide" (1 trials) and "Epirubicin" (1 trials). Other intervention names were less common.

The vast majority of trials in "H. Río Carrión" are 6 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "H. Río Carrión". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in H. Río Carrión, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in H. Río Carrión, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".